源于尾状叶的肝细胞癌介入治疗进展
Advances in the interventional therapy of hepatocellular carcinoma originating from the caudate lobe.
作者信息
Ke Shanmiao
机构信息
The Second Affiliated Hospital of Nanchang University, Department of Gastroenterology, Nanchang, 330006, China.
出版信息
J Interv Med. 2022 May 21;5(2):51-56. doi: 10.1016/j.jimed.2022.03.002. eCollection 2022 May.
UNLABELLED
Hepatocellular carcinoma originating from the caudate lobe, also known as segment I hepatocellular carcinoma, is difficult to treat because of its special location, complex vascular supply, and the proximity of important vessels, bile ducts, and organs. This research is conducted to examine the efficacy and safety of interventional therapy for hepatocellular carcinoma in the caudate lobe.
CONCLUSION
Superselective chemoembolization and ablation techniques for the treatment of caudate lobe hepatocellular carcinoma still need to be improved. The combination of multiple interventional methods and the application of multiple imaging techniques can improve the effectiveness and safety of interventional therapy for hepatocellular carcinoma in the caudate lobe. Multidisciplinary treatment is also essential to improve the prognosis of patients with caudate lobe hepatocellular carcinoma.
未标注
起源于尾状叶的肝细胞癌，也称为Ⅰ段肝细胞癌，由于其特殊的位置、复杂的血管供应以及重要血管、胆管和器官的临近，治疗困难。本研究旨在探讨尾状叶肝细胞癌介入治疗的疗效和安全性。
结论
尾状叶肝细胞癌的超选择性化疗栓塞和消融技术仍需改进。多种介入方法的联合应用以及多种成像技术的运用可提高尾状叶肝细胞癌介入治疗的有效性和安全性。多学科治疗对于改善尾状叶肝细胞癌患者的预后也至关重要。
Zotero 插件